Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
gosogliptin (1 trial)
Diabetes Mellitus, Type 2 (Phase 3)
Trials (1 total)
Trial APIs (1 total)